Binance’s BIO Protocol has achieved remarkable success in its fundraising efforts, securing a total of $30.2 million through a combination of private and public offerings.
The private funding was conducted in two rounds, raising $2.3 million at valuations of $35 million and $69 million respectively.
The public offering phase, known as the BIO Genesis auction, was executed in three stages, generating $27.9 million with progressively increasing valuations of $85 million, $142 million, and $219 million.
Currently, based on pre-market trading data from Bybit and Bitget as of December 29, BIO’s fully diluted valuation (FDV) stands at approximately $3.2 billion, with an average trading price of $0.9659, demonstrating significant market interest and value appreciation.
Token Distribution and Investment Returns
The BIO Protocol’s token structure reveals a maximum circulation of 3.32 billion tokens (dynamic), with 13.60% allocated to private investors and 20.00% designated for public investors. The investment returns have been exceptional across all participation stages.
Private seed round investors, who entered at approximately $0.01054 per token, have seen remarkable returns of 91.62 times their initial investment.
Seed round participants, with an entry price of $0.02078, are experiencing 46.48 times profit.
Public offering participants have also achieved significant gains, with Round 1 investors ($0.0256 entry) seeing 37.73 times returns, Round 2 ($0.04277) achieving 22.58 times, and Round 3 ($0.06596) reaching 14.64 times their initial investment.
Also Read: Binance Futures Launches “NEXT WAVE” Campaign With Lamborghini Giveaway
Token Unlocking Strategy and Market Impact
The project has implemented a strategic token unlocking mechanism to manage potential selling pressure. Private investors’ tokens are subject to a complete lock at the Token Generation Event (TGE).
Public investors will receive 50% of their tokens at TGE, with the remaining 50% unlocking linearly over one year.
The structure means that only 10% of the total token supply (equivalent to 25.6% of the circulation) will be released at TGE, amounting to 332 million tokens.
Based on pre-market prices, this represents approximately $320 million in value. This controlled unlocking strategy aims to minimize immediate selling pressure and promote price stability.
Binance’s Broader Project Ecosystem and Future Outlook
The success of the BIO Protocol adds to Binance’s track record of supporting innovative projects.
Evidenced by recent developments such as their support for Fantom’s Sonic rebrand, scheduled for early 2025, and Binance Labs’ investment in the stablecoin issuer Usual, which saw a 33% price surge following the announcement.
The impressive performance of BIO Protocol, particularly its high return multiples across all investment rounds, suggests strong market confidence in Binance-backed projects.
The careful structuring of token distribution and unlocking mechanisms indicates a strategic approach to maintaining long-term project value while managing market dynamics.
Also Read: Binance To Support Fantom’s Sonic Rebrand, FTM Delisting & New Sonic Trading Pairs Launch